Purity >90%, by SDS-PAGE. MW (theoretical): 84 kDa. The Recombinant Human Lck Protein from Novus Biologicals is derived from Sf 9 (baculovirus). The Recombinant Human Lck Protein has been validated for the following applications: SDS-Page, Bioactivity.
Size
0.005 mg
Concentration
0.1 mg/ml
Applications
SDS-Page, Bioactivity
Other Names
EC 2.7.10, EC 2.7.10.2, Leukocyte C-terminal Src kinase, LSK, Lymphocyte cell-specific protein-tyrosine kinase, lymphocyte-specific protein tyrosine kinase, p56(LSTRA) protein-tyrosine kinase, p56lck, p56-LCK, pp58lck, Protein YT16, Proto-oncogene Lck, proto-oncogene tyrosine-protein kinase LCK, T cell-specific protein-tyrosine kinase, T-lymphocyte specific protein tyrosine kinase p56lck, tyrosine-protein kinase Lck, YT16